Apontis Pharma AG (FRA:APPH)
Germany · Delayed Price · Currency is EUR 10.75
+0.05 (0.47%)
At close: Jul 18, 2025, 10:00 PM CET
Apontis Pharma AG Company Description
Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes.
The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.
Apontis Pharma AG
| Country | Germany |
| Founded | 1946 |
| Industry | Pharmaceutical Preparations |
| Employees | 137 |
| CEO | Bruno Wohlschlegel |
Contact Details
Address: Alfred-Nobel-Str. 10 Monheim am Rhein, 40789 Germany | |
| Phone | 49 2173 8955 4949 |
| Website | apontis-pharma.de |
Stock Details
| Ticker Symbol | APPH |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bruno Wohlschlegel | Chief Executive Officer |
| Thomas Zimmermann | Chief Financial Officer |